newsfilter
← Latest News
GlobeNewswire·

Diffusion Pharmaceuticals Completes Dosing in Altitude Trial

Topline data expected within two months Blinded, interim data to be presented at the Undersea & Hyperbaric Medical Society's Annual Scientific Meeting in May 2022 CHARLOTTESVILLE, Va., April 11, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals